Allergy Therapeutics PLC (LON:AGY) target price held steady at 53.00GBX, issued a report today by Panmure Gordon
- Updated: September 25, 2016
Yesterday Allergy Therapeutics PLC (LON:AGY) traded -2.86% lower at 17.63GBX. The company’s 50-day moving average is 18.77GBX and its 200-day moving average is 22.69GBX. The last closing price is down -21.34% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 214,033 shares of the stock were exchanged, down from an average trading volume of 256,727
Allergy Therapeutics PLC (LON:AGY) had its target price hold steady to 53.00GBX by Panmure Gordon in a report released 9/26/2016. The new target price indicates a possible upside of 2.01% based on the company's last closing price.
Previously on 09/21/2016, Numis reported on Allergy Therapeutics PLC (LON:AGY) raised the target price from 0.00GBX to 37.00GBX. At the time, this indicated a possible upside of 1.01%.
See Chart Below
Allergy Therapeutics PLC has a 52 week low of 17.29GBX and a 52 week high of 34.82GBX The company’s market cap is currently 0 GBX.
In addition to Panmure Gordon reporting its target price, a total of 3 brokers have issued a report on the stock. The consensus target price is 64.67GBX with 1 broker rating the stock a strong buy, 1 broker rating the stock a buy, 0 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.
General Information About Allergy Therapeutics PLC (LON:AGY)
Allergy Therapeutics Plc is a United Kingdom-based pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum free products. It provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's business segments are Central Europe, which includes segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes segments, such as Italy and Spain; the United Kingdom, which includes Latin America, and Rest of World. It offers products, such as Pollinex Trees, Pollinex Grasses + Rye and Skin Prick Testing; Diagnostic Products, such as Pollen, Foods, Moulds, Arthropods and Epithelia, and the United Kingdom Special products, including Pollinex Quattro, Tyrosine TU t.o.p, Oralvac Compact, and DAP Penicillin/DAP Amoxicillin/DAP Clavulanic.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.